444 related articles for article (PubMed ID: 26892650)
1. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):395-407; quiz 408-10. PubMed ID: 26892650
[TBL] [Abstract][Full Text] [Related]
2. Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):411-20; quiz 421-2. PubMed ID: 26892651
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
4. Management of familial melanoma and nonmelanoma skin cancer syndromes.
Santillan AA; Cherpelis BS; Glass LF; Sondak VK
Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
[TBL] [Abstract][Full Text] [Related]
5. Familial melanoma; CDKN2A and beyond.
Gruis NA; van der Velden PA; Bergman W; Frants RR
J Investig Dermatol Symp Proc; 1999 Sep; 4(1):50-4. PubMed ID: 10537008
[TBL] [Abstract][Full Text] [Related]
6. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.
Levin T; Mæhle L
Fam Cancer; 2017 Apr; 16(2):257-265. PubMed ID: 27804060
[TBL] [Abstract][Full Text] [Related]
7. Molecular landscape of Hereditary Melanoma.
Ribeiro Moura Brasil Arnaut J; Dos Santos Guimarães I; Evangelista Dos Santos AC; de Moraes Lino da Silva F; Machado JR; de Melo AC
Crit Rev Oncol Hematol; 2021 Aug; 164():103425. PubMed ID: 34245855
[TBL] [Abstract][Full Text] [Related]
8. A questionnaire survey of Midwest dermatologists on the clinical-genetic aspects of patients with multiple atypical nevi.
Fusaro RM; Johnsen LR; Hoden RH; Lynch HT
Nebr Med J; 1993 May; 78(5):132-7. PubMed ID: 8316319
[TBL] [Abstract][Full Text] [Related]
9. The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome".
Ipenburg NA; Gruis NA; Bergman W; van Kester MS
J Am Acad Dermatol; 2016 Oct; 75(4):e157. PubMed ID: 27646763
[No Abstract] [Full Text] [Related]
10. Genetics of familial atypical multiple mole-melanoma (FAMMM) syndrome in The Netherlands: how far have we come?
Gruis NA; Van der Velden PA; Bergman W; Frants RR
Bull Cancer; 1998 Jul; 85(7):627-30. PubMed ID: 9752270
[TBL] [Abstract][Full Text] [Related]
11. Familial skin cancer syndromes: Increased melanoma risk.
Ransohoff KJ; Jaju PD; Tang JY; Carbone M; Leachman S; Sarin KY
J Am Acad Dermatol; 2016 Mar; 74(3):423-34; quiz 435-6. PubMed ID: 26892652
[TBL] [Abstract][Full Text] [Related]
12. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM).
Noë M; Hackeng WM; de Leng WWJ; Vergeer M; Vleggaar FP; Morsink FHM; Wood LD; Hruban RH; Offerhaus GJA; Brosens LAA
Am J Surg Pathol; 2019 Sep; 43(9):1297-1302. PubMed ID: 31261289
[TBL] [Abstract][Full Text] [Related]
13. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
14. Familial melanoma and multiple primary melanoma.
DE Simone P; Valiante M; Silipo V
G Ital Dermatol Venereol; 2017 Jun; 152(3):262-265. PubMed ID: 28121081
[TBL] [Abstract][Full Text] [Related]
15. CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: a clinical dermoscopic genetic study.
De Giorgi V; Savarese I; D'Errico A; Gori A; Papi F; Colombino M; Sini MC; Stanganelli I; Palmieri G; Massi D
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):574-80. PubMed ID: 25200134
[TBL] [Abstract][Full Text] [Related]
16. CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome.
Cremin C; Howard S; Le L; Karsan A; Schaeffer DF; Renouf D; Schrader KA
Hered Cancer Clin Pract; 2018; 16():7. PubMed ID: 29541281
[TBL] [Abstract][Full Text] [Related]
17. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.
Borroni RG; Manganoni AM; Grassi S; Grasso M; Diegoli M; Giorgianni C; Favalli V; Pavoni L; Cespa M; Arbustini E
Melanoma Res; 2017 Apr; 27(2):97-103. PubMed ID: 28060055
[TBL] [Abstract][Full Text] [Related]
18. German national case collection of familial pancreatic cancer - clinical-genetic analysis of the first 21 families.
Rieder H; Sina-Frey M; Ziegler A; Hahn SA; Przypadlo E; Kress R; Gerdes B; Colombo Benkmann M; Eberl T; Grützmann R; Lörken M; Schmidt J; Bartsch DK
Onkologie; 2002 Jun; 25(3):262-6. PubMed ID: 12119461
[TBL] [Abstract][Full Text] [Related]
19. Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.
Lynch HT; Fusaro RM; Lynch JF
Future Oncol; 2007 Apr; 3(2):169-81. PubMed ID: 17381417
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of melanoma genetics.
Gabree M; Patel D; Rodgers L
Curr Treat Options Oncol; 2014 Jun; 15(2):336-50. PubMed ID: 24652319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
